Table 2.
Differences in clinical characteristics and radiographic measurement
| CONUT | ||||
|---|---|---|---|---|
| All patients (n = 134) |
Low ( ≤ 3) n = 58 |
High ( ≥ 4) n = 76 |
P-value | |
| Age, years W | 83.5 ± 7.6 | 81.9 ± 7.4 | 84.7 ± 7.7 | 0.042* |
| Sex (n, % female) | 89 (66) | 42 (72) | 47 (62) | 0.20 |
| BMI (kg/m2) | 20.8 ± 4.3 | 22.7 ± 5.0 | 19.3 ± 3.7 | 0.001* |
| Comorbidities (%) | 112 (84) | 46 (79) | 66 (87) | 0.25 |
| Hypertension | 60 (45) | 31 (53) | 29 (38) | 0.078 |
| Diabetes | 25 (19) | 9 (16) | 16 (21) | 0.41 |
| Cardiovascular disease | 23 (17) | 9 (16) | 14 (18) | 0.66 |
| Dementia | 23 (17) | 8 (14) | 15 (20) | 0.36 |
| Cerebrovascular disease | 10 (7) | 3 (5) | 7 (9) | 0.37 |
| Malignant disease | 9 (7) | 3 (5) | 6 (8) | 0.53 |
| Chronic lung disease | 8 (6) | 3 (5) | 5(7) | 0.73 |
| Osteoporosis treatment (%) | 20 (15) | 11 (19) | 9 (12) | 0.25 |
| Hb (g/dl) | 11.67 ± 1.92 | 12.57 ± 1.67 | 10.96 ± 1.82 | 0.001* |
| Albumin (g/dl) | 3.38 ± 0.57 | 3.80 ± 0.29 | 3.05 ± 0.52 | 0.001* |
| Total lymphocyte cells (/mm3) | 1183.7 ± 538.2 | 1394.8 ± 561.9 | 1022.7 ± 461.5 | 0.001* |
| Total cholesterol (mg/dl) | 174.9 ± 41.3 | 199.9 ± 37.2 | 155.8 ± 33.4 | 0.001* |
| Level of AOVF, n (%) | ||||
| T10- | 21 (16) | 9 (16) | 12 (16) | 0.97 |
| L1-T11 | 66 (49) | 27 (47) | 39 (51) | 0.58 |
| L2-5 | 60 (45) | 25 (43) | 35 (46) | 0.73 |
| Multiple AOVFs, n (%) | 21 (16) | 5 (9) | 16 (21) | 0.048* |
| Prevalent OVFs, n (%) | 58 (43) | 20 (34) | 38 (50) | 0.071 |
| Lumbar Lordosis (°) | 35.6 ± 14.2 | 36.5 ± 14.6 | 35.1 ± 13.9 | 0.54 |
| BMD (g/cm2) | 0.81 ± 0.14 | 0.83 ± 0.17 | 0.77 ± 0.084 | 0.61 |
CONUT, Controlling Nutritional Status, BMI, body mass index, Hb, hemoglobin, AOVFs, acute osteoporotic vertebral fractures, OVFs, osteoporotic vertebral fractures, BMD, bone mineral density
* P-value 0.05 statistically significant difference